6-month cohort-based program for therapeutic companies
Weekly seminars, office hours, tangible templates, executive coaching, and more
Building the foundation and confidence to achieve traction with investors
1-year program for therapeutics and in vitro diagnostics companies
Gap analysis, 40hrs of consulting, representation at investor conferences, and more
Identify and overcome hurdles in your corporate and product development
2-year program, available by invitation only
Funding, rent-free lab placement, 300 hrs/year of consulting, and all the perks of RIDGE
Accelerate your path to Series A investment and the clinic
No, CBV programming is offered to companies at no cost! For companies that have graduated from, or are not eligible for our programming, we encourage you to consider subscribing to become a CBV member.
Yes, companies must graduate from ASCENT to be eligible for RIDGE or SUMMIT unless an exception is approved by the CBV Leadership. ASCENT provides companies with the foundation required to build an investable biotech company and helps companies identify gaps and priorities in their corporate and product development roadmap. ASCENT also provides CBV an opportunity to assess a company’s commitment, willingness to learn, and overall likelihood of success for financing.
No. If companies wish to continue to access CBV programming, they can do so via membership. Contact us for more details about our membership offerings.
Yes, CBV programming is complimentary to other programs across Canada. Our programming is geared towards therapeutics and in vitro diagnostics companies and includes several unique and differentiated offerings.
